Why an ovary syndrome may get a new name: Men seem to have PCOS, too
-
By
-
Annalisa Merelli
-
April 1, 2026
-
Clinical Scorecard: Reevaluating Polycystic Ovary Syndrome: Exploring Its Relevance in Male Health
At a Glance
| Category | Detail |
|---|
| Condition | Polycystic Ovary Syndrome (PCOS) |
| Key Mechanisms | High androgen levels, insulin resistance, metabolic disruptions |
| Target Population | Reproductive-age women and potentially male relatives |
| Care Setting | Endocrinology and metabolic health |
Key Highlights
- PCOS affects up to 13% of reproductive-age women, with 70% undiagnosed.
- Diagnosis requires two of three symptoms: ovulatory dysfunction, androgen excess, polycystic ovarian morphology.
- The condition is being reframed as a metabolic disease rather than solely reproductive.
- Research suggests familial metabolic disorders in male relatives of women with PCOS.
- Proposed name changes for PCOS include reproductive metabolic syndrome.
Guideline-Based Recommendations
Diagnosis
- Utilize Rotterdam criteria for PCOS diagnosis: ovulatory dysfunction, androgen excess, polycystic ovarian morphology.
Management
- Lifestyle interventions combined with hormonal treatments are recommended.
Monitoring & Follow-up
- Screen male relatives for metabolic disorders when a female relative is diagnosed with PCOS.
Risks
- Increased risk of diabetes, cardiovascular disease, and mental health issues.
Patient & Prescribing Data
Women of reproductive age with PCOS and their male relatives.
Management focuses on symptom relief and metabolic health.
Clinical Best Practices
- Consider metabolic health in the diagnosis and management of PCOS.
- Educate patients about the familial nature of metabolic disorders associated with PCOS.
References
